🇺🇸 FDA
Pipeline program

AU-011

AU-011-203

Phase 2 small_molecule active

Quick answer

AU-011 for Eye Cancer is a Phase 2 program (small_molecule) at Aura Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Aura Biosciences
Indication
Eye Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials